Skip to main navigation

Contact
Info
CRISPR/Cas9
Programs
Investors & Media
Careers

Email Alerts

Shareholder Services

Investor FAQs
Information Request
Email Alerts
IR & Media Contacts

Email Alerts

Required fields denoted by an asterisk ().

Alert type
SEC Alert
Calendar Alert
News Alert

Email

Investors

Investor Relations

investor relations
press releases
events & presentations
corporate governance
financial information
stock information
analyst coverage
investor FAQs
information request
IR & Media Contacts

Info

Overview
Leadership
Partners

Careers

Our DNA
Why We’re Here
Job Openings
Benefits

CRISPR/Cas9

What’s CRISPR/Cas9?
How CRISPR/Cas9 Works
Types of Edits

Programs

Our Full-Spectrum Approach
Pipeline
In Vivo Therapies
Ex Vivo Therapies

Investors & Media

Press Releases
Scientific Publications and Presentations
Corporate Deck
Events & Presentations
Press Kit

© Intellia Therapeutics 2020

terms of use
privacy policy

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.